oral glp 1 agonist for type 2 diabetes NEW: This new GLP-1 could be a game-changer people with diabetes. Swipe to learn more about orforglipron and visit the link in our bio for the full story Management of type 2 diabetes

These programs are less widely known but can be genuinely impactful for people who meet the eligibility criteria

Various mechanisms have been theorized to describe how dual agonism, as GLP-1 RA, could directly reduce triglycerides hepatocyte storage, lipogenesis and improving hepatic glucose metabolism (96) and promoting lipolysis and fatty acid oxidation (97)

And they will say, I go to a restaurant, I have my hunger cues, but I'm satisfied with much less food than I used to eat before, and my body weight is maintained

P = .003) were lower in the GLP-1 RA group, but mean (SD) body mass index (BMI) did not differ at follow-up (40.6 [9.2] vs 39.5 [8.7]

Diabetes Metab Res Rev (2021) 37(1):e3353

Deeply understand physician and payer dynamics, and build strategy accordingly: Deeply understand physician and payer dynamics, and build strategy accordingly: Understanding the differences between primary care provider versus endocrinologist perceptions and prescribing behaviors (e.g., class preferences, route of administration preferences, etc.) is foundational to developing strategies that account for stakeholder-specific nuances